Knockdown of BCAT2 in oestrogen receptor-positive (MCF7) cells was shown to result in reduced proliferation in contrast to normal-like MCF-10A breast cells and airway smooth muscle (ASM) cells where no effect on cell proliferation was observed [54] indicating tumour-selective BCAT2-mediated inhibition of cell growth. Here, BCAT2 is linked to neoplasm.